The CRBN gene, encoding cereblon, is a ubiquitously expressed protein that plays a critical role in the ubiquitin-proteasome system. Cereblon functions as an E3 ubiquitin ligase substrate receptor, participating in the degradation of specific target proteins. Notably, cereblon is best known for its involvement in the mechanism of action of thalidomide and its analogs, which are used therapeutically in the treatment of multiple myeloma and other hematological malignancies. These drugs enhance the binding affinity of cereblon for neomorphic substrates, leading to their ubiquitination and subsequent degradation.